179 related articles for article (PubMed ID: 23845726)
1. CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration.
Lin TH; Liu HH; Tsai TH; Chen CC; Hsieh TF; Lee SS; Lee YJ; Chen WC; Tang CH
Biochim Biophys Acta; 2013 Oct; 1830(10):4917-27. PubMed ID: 23845726
[TBL] [Abstract][Full Text] [Related]
2. BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK.
Du C; Zheng Z; Li D; Chen L; Li N; Yi X; Yang Y; Guo F; Liu W; Xie X; Xie M
Oncotarget; 2016 Jun; 7(26):40174-40188. PubMed ID: 27233075
[TBL] [Abstract][Full Text] [Related]
3. Indole-3-carbinol and 3',3'-diindolylmethane modulate androgen's effect on C-C chemokine ligand 2 and monocyte attraction to prostate cancer cells.
Kim EK; Kim YS; Milner JA; Wang TT
Cancer Prev Res (Phila); 2013 Jun; 6(6):519-29. PubMed ID: 23585426
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCδ/c-Src dependent signaling pathway.
Yu HS; Lin TH; Tang CH
Prostate; 2013 Jan; 73(1):89-100. PubMed ID: 22653778
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity.
Ito Y; Ishiguro H; Kobayashi N; Hasumi H; Watanabe M; Yao M; Uemura H
Prostate; 2015 Jul; 75(10):1009-19. PubMed ID: 25917126
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling.
Montagnani Marelli M; Moretti RM; Procacci P; Motta M; Limonta P
Int J Oncol; 2006 Mar; 28(3):723-30. PubMed ID: 16465378
[TBL] [Abstract][Full Text] [Related]
7. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
9. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways.
Tang CH; Lu ME
Prostate; 2009 Dec; 69(16):1781-9. PubMed ID: 19676095
[TBL] [Abstract][Full Text] [Related]
11. The CCL2-CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells.
Natsagdorj A; Izumi K; Hiratsuka K; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Shigehara K; Nakata H; Mizokami A
Anticancer Res; 2023 Jun; 43(6):2561-2569. PubMed ID: 37247914
[TBL] [Abstract][Full Text] [Related]
12. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
Chiu HY; Sun KH; Chen SY; Wang HH; Lee MY; Tsou YC; Jwo SC; Sun GH; Tang SJ
Cytokine; 2012 Aug; 59(2):423-32. PubMed ID: 22617682
[TBL] [Abstract][Full Text] [Related]
13. RNAi targeting of CCR2 gene expression induces apoptosis and inhibits the proliferation, migration, and invasion of PC-3M cells.
Gao J; Wang A; Zhang M; Li H; Wang K; Han Y; Wang Z; Shi C; Wang W
Oncol Res; 2013; 21(2):73-82. PubMed ID: 24406043
[TBL] [Abstract][Full Text] [Related]
14. A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling.
Huang M; Narita S; Numakura K; Tsuruta H; Saito M; Inoue T; Horikawa Y; Tsuchiya N; Habuchi T
Prostate; 2012 Dec; 72(16):1779-88. PubMed ID: 22514016
[TBL] [Abstract][Full Text] [Related]
15. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.
Zhang J; Lu Y; Pienta KJ
J Natl Cancer Inst; 2010 Apr; 102(8):522-8. PubMed ID: 20233997
[TBL] [Abstract][Full Text] [Related]
16. CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway.
Tang CH; Tsai CC
Biochem Pharmacol; 2012 Feb; 83(3):335-44. PubMed ID: 22138288
[TBL] [Abstract][Full Text] [Related]
17. The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.
He S; He S; Chen CH; Deborde S; Bakst RL; Chernichenko N; McNamara WF; Lee SY; Barajas F; Yu Z; Al-Ahmadie HA; Wong RJ
Mol Cancer Res; 2015 Feb; 13(2):380-90. PubMed ID: 25312961
[TBL] [Abstract][Full Text] [Related]
18. N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
Nalla AK; Estes N; Patel J; Rao JS
Exp Cell Res; 2011 Oct; 317(17):2512-21. PubMed ID: 21855541
[TBL] [Abstract][Full Text] [Related]
19. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
[TBL] [Abstract][Full Text] [Related]
20. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]